Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketogenic Diet and Letrozole in ER+ Breast Cancer
NCT03962647Phase 1Completed
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Start
- Jul 2019
- Primary completion
- Mar 2024
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in breast cancer (2 arms), sponsored by Vanderbilt-Ingram Cancer Center. Primary endpoint: Patients who complete the dietary intervention at 2 weeks. Started Jul 2019; status: completed.
02
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03962647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03962647.